Skip to main content
Top

Drugs

Issue 16/2022

Content (6 Articles)

Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors

Francesco Locatelli, Roberto Minutolo, Luca De Nicola, Lucia Del Vecchio

Darinaparsin: First Approval

James E. Frampton

Correction to: Darinaparsin: First Approval

  • Correction

James E. Frampton

Teclistamab: First Approval

Connie Kang

Valemetostat Tosilate: First Approval

  • Open Access
  • Lymphoma
  • AdisInsight Report

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images